Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

X4 Pharmaceuticals Inc

4.09
+0.27007.07%
Post-market: 4.260.1700+4.16%18:39 EDT
Volume:402.40K
Turnover:1.64M
Market Cap:371.86M
PE:-2.18
High:4.17
Open:3.85
Low:3.85
Close:3.82
52wk High:8.70
52wk Low:1.35
Shares:90.92M
Float Shares:64.61M
Volume Ratio:0.94
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8726
EPS(LYR):-5.5878
ROE:-75.99%
ROA:-22.85%
PB:2.00
PE(LYR):-0.73

Loading ...

OverviewCompanyNewsFilings

X4 Pharmaceuticals Reports $240 Million Financing and Shifts Focus to Phase 3 Chronic Neutropenia Trial

Reuters
·
Nov 05, 2025

X4 Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Nov 05, 2025

X4 Pharmaceuticals Raises $155.3 Million in Public Offering

Reuters
·
Oct 28, 2025

X4 Pharmaceuticals Executive Chairman Adam R. Craig Reports Acquisition of Common Shares

Reuters
·
Oct 28, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Cipher Mining, Kura, GrafTech

Reuters
·
Oct 24, 2025

X4 Pharmaceuticals Prices $135 Million Public Offering of Common Stock and Pre-Funded Warrants

Reuters
·
Oct 24, 2025

X4 Pharmaceuticals Inc - Prices Public Offering at $2.90 per Share

THOMSON REUTERS
·
Oct 24, 2025

X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering

THOMSON REUTERS
·
Oct 24, 2025

BRIEF-X4 Pharmaceuticals Announces Proposed Underwritten Public Offering

Reuters
·
Oct 24, 2025

X4 Pharmaceuticals Inc - Proceeds to Fund Phase 3 Development of Mavorixafor

THOMSON REUTERS
·
Oct 24, 2025

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Mar 17, 2026 Pre-Market
Financial Report Announcement
Nov 05, 2025 Pre-Market
Financial Report Announcement
Aug 08, 2025 Post Market
Financial Report Announcement
May 01, 2025 Pre-Market
Split&Reverse Split
Apr 28, 2025 30 for 1

Dividend History

no data

No relevant data is available

Valuation Analysis

-2.04
Current
-1.28
Sector Average
4.10%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-2.04
Maximum
7.26
+1 STD
0.99
Minimum
-8.20
-1 STD
-3.56
Average
-1.28

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.